| |
 |

+ Larger Font / - Smaller Font

Diabetic
Retinopathy
The American Diabetes Association estimates that approximately 18.2 million people,
6.3 percent of the population, have diabetes. Diabetic complications
are the leading cause of irreversible blindness in patients under 65 and is now responsible
for anywhere from 12,000 to 24,000 new cases of
blindness each year. For diabetics over the age of 40, one in every twelve will develop diabetic
retinopathy.
The National Diabetes Information Clearinghouse
(NDIC) found in their study conducted from 1983-1993 that maintaining
blood sugars close to normal can significantly slow the progression
of retina, kidney, and nerve diseases.
There are two forms of diabetic retinopathy: background
and proliferative
Background diabetes retinopathy is manifested by early retinal hemorrhages
and possibly edema which significantly affects vision. Proliferative
diabetes retinopathy occurs because of ischemia (abnormal reduction
of blood supply) of the retina. The ischemia causes a serge of Vascular
Endothelial Growth Factor (VEGF) which produces new, defective blood
vessel growth. These new, defective blood vessels can leak and cause
vitreous hemorrhage. The new vessels can also cause scarring which
prevents tissue growth. The scar tissue can shrink, wrinkle and pull
on the retina causing it to detach.
Symptoms
Patients with background diabetic retinopathy may not have any symptoms initially. That is
why it is so important to encourage regular ophthalmic visits for this population. This is a
preventable disease if caught early. When edema, scarring, and hemorrhages occur, the patient
will experience vision loss. Symptoms widely depend on the stage of the disease.
Patients may
complain of
blurred vision
floaters and flashes
and sudden loss of vision.
Risk Factors
Gestational diabetes
American Indians/Alaska Natives are at most risk for diabetes
Obesity
Treatments
Lifestyle changes: The most important treatment is maintaining good diabetic control through
a careful diet and exercise program, losing excess weight, and taking medication as prescribed.
Good control of cholesterol and blood pressure.
Other treatments your physician my prescribe:
Panretinal photocoagulation (PRP): A laser is directed to the damaged retina. When the laser hits the
blood or pigment in the retina, it is absorbed as heat energy and produces many small burns on the edges
of the retina. The burns produce small scars. This method is believed to reduce the production of
insufficient blood vessels.
Surgery: Sometimes surgery is indicated to remove hemorrhages in the vitreous and repair a detached
retina.
The overall goal for diabetic retinopathy is to stablilize the vision and prevent further vision loss.
Future Treatments:
Because our aging population is growing, there is a renewed interest in advancing retina treatments. Those
treatments are outlined below:
Anti VEGF treatments: Medication is injected into the vitreous approximately
every 6 weeks. Names of the medications included in this category: Macugen,
Lucintis and Retaane.
Additional
information regarding VEGF: When
pigment epithelium becomes stressed, it sends out a distress signal.
This signal results in the body increasing VEGF, which stimulates
the growth of defective vessels. These medications stop this process.
Retina Microchips: These microchips can be implanted in the back of the eye to function as an artifical
retina.
Stem Cell Transplantation: Stem cell is a promising option to cure retina diseases repopulating the diseased tissue.
Special thanks to National Eye Institute,
National Institutes of Health
Other Suggested Links:
American Diabetes Association
American Academy of Ophthalmology
American Foundation for the Blind
American Optometric Association
EyeCare America
Prevent Blindness America
West Texas Retina Consultants
Sunil S. Patel, M.D., Ph.D.
S. Young Lee, M.D.
5441 Health Center Dr.
Abilene, Texas 79606
800-810-7411
325-673-9806
info@westtexasretina.com
|
 |